Virogin Biotech: Funding, Investors & Team (Sep 2026)
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
Virogin Biotech has raised $120M across 1 funding round on record, the most recent a Series D of $120M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Virogin Biotech Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Virogin Biotech Funding Rounds
Virogin Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Virogin Biotech Funding Compared to Other Biotechnology Startups
Virogin Biotech's latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Virogin Biotech in Biotechnology and Vancouver
Companies Similar to Virogin Biotech
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Virogin Biotech Funding FAQs
What does Virogin Biotech do?
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
How much funding has Virogin Biotech raised?
Virogin Biotech has raised $120M across 1 round on record. The most recent is a Series D of $120M announced in Sep 2021.
When did Virogin Biotech last raise funding?
Virogin Biotech's most recent funding round on record is a Series D of $120M, announced in Sep 2021.
Who is the CEO of Virogin Biotech?
Chris Huang is listed as CEO at Virogin Biotech.
Where is Virogin Biotech headquartered?
Virogin Biotech is based in Vancouver, British Columbia, Canada.
How many employees does Virogin Biotech have?
Virogin Biotech is in the 11-50 employee band.
How does Virogin Biotech's funding compare to other Biotechnology startups?
Virogin Biotech's latest round of $120M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Virogin Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Virogin Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.